Access cutting-edge open angle glaucoma treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access open angle glaucoma specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related open angle glaucoma treatment provided free
The objective of this study is to determine if a combination of oral nicotinamide and pyruvate (N\&P) can maintain eye health as compared to placebo while standard-of-care intraocular pressure-lowering glaucoma medications are used to treat glaucoma. A total of up to 188 participants will be enrolled and randomized 1:1 to receive N\&P or placebo for 87 weeks (20 months). Participants will be followed for a total of 91 weeks (21 months).
Sponsor: Columbia University
Check if you qualify for this open angle glaucoma clinical trial in New York, NY
If you're searching for open angle glaucoma treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced open angle glaucoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.